Paper8400331
Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
Kennedy MJ and 1 other. Breast Cancer Res Treat, 1993. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation. Papers, record 8400331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8400331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bone Marrow Transplantation | Major topic |
| Breast Neoplasms | Major topic |
| Graft vs Host Disease | Major topic |
| Immunotherapy | Major topic |
| Animals | |
| Combined Modality Therapy | |
| Cyclosporine | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Interferon-gamma |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 58270-01 | NCI NIH HHS | United States | PubMed | PubMed | |
| U01CA058270 | NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34792 | Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. | N Engl J Med | 1979 | https://conductscience.org/library/papers/34792 | PubMed |
| 2 | 1357109 | High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1357109 | PubMed |
| 3 | 3918946 | Induction of HLA class-II antigen expression on human carcinoma cell lines by IFN-Gamma. | Int J Cancer | 1985 | https://conductscience.org/library/papers/3918946 | PubMed |
| 4 | 6336658 | Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. | Cancer Res | 1983 | https://conductscience.org/library/papers/6336658 | PubMed |
| 5 | 6403654 | Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. | J Exp Med | 1983 | https://conductscience.org/library/papers/6403654 | PubMed |
| 6 | 2049460 | Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. | Ann Hematol | 1991 | https://conductscience.org/library/papers/2049460 | PubMed |
| 7 | 2815290 | Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants. | Transplant Proc | 1989 | https://conductscience.org/library/papers/2815290 | PubMed |
| 8 | 2459333 | HLA class II sublocus expression in benign and malignant breast epithelium. | J Pathol | 1988 | https://conductscience.org/library/papers/2459333 | PubMed |
| 9 | 8445424 | Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8445424 | PubMed |
| 10 | 1740685 | Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1740685 | PubMed |
| 11 | 3924395 | Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression. | Cancer Res | 1985 | https://conductscience.org/library/papers/3924395 | PubMed |
| 12 | 1727912 | A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1727912 | PubMed |
| 13 | 8435355 | Reversal of multidrug resistance in breast cancer: many more open questions than answers. | Ann Oncol | 1993 | https://conductscience.org/library/papers/8435355 | PubMed |
| 14 | 2502208 | Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat. | Blood | 1989 | https://conductscience.org/library/papers/2502208 | PubMed |
| 15 | 2580038 | Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. | J Exp Med | 1985 | https://conductscience.org/library/papers/2580038 | PubMed |
| 16 | 3043792 | Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period. | Transplantation | 1988 | https://conductscience.org/library/papers/3043792 | PubMed |
| 17 | 2941082 | Immunologic classification of leukemia and lymphoma. | Blood | 1986 | https://conductscience.org/library/papers/2941082 | PubMed |
| 18 | 7015133 | Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. | N Engl J Med | 1981 | https://conductscience.org/library/papers/7015133 | PubMed |
| 19 | 1991174 | Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. | Blood | 1991 | https://conductscience.org/library/papers/1991174 | PubMed |
| 20 | 3047332 | High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. | J Clin Oncol | 1988 | https://conductscience.org/library/papers/3047332 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12621492 | Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). | Bone Marrow Transplant | 2003 | https://conductscience.org/library/papers/12621492 | PubMed |
| 8825121 | Immunomodulation following chemotherapy. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8825121 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8400331
GET https://conductscience.org/api/papers/v1/8400331/references?page=2